SAB Biotherapeutics, Inc. (SABS) - Stock Prices, Stock Peers & Analysis

Home
SABS

Company Name	SAB Biotherapeutics, Inc.
Symbol	SABS
Currency	USD
Price	2.76
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	25,472,785
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	2.16 - 10.5
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Eddie Joe Sullivan Ph.D.
Website	https://www.sabbiotherapeutics.com

An error occurred while fetching data.

About SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune